Get answers to your questions about SUSVIMO and explore wet AMD resources.
SUSVIMO is a prescription medicine used to treat adults with neovascular (wet) Age-related Macular Degeneration (AMD) who have responded to at least two injections of a Vascular Endothelial Growth Factor (VEGF) inhibitor in the gel-like part of the eye (intravitreal). It is not known if SUSVIMO is safe and effective in children.
SUSVIMO delivers a formulation of ranibizumab, a wet AMD medication relied on by Retina Specialists, through an implant placed in your eye. The SUSVIMO implant continuously delivers ranibizumab into your eye for 6 months to help maintain your vision.
Yes. Treatment with SUSVIMO requires a Retina Specialist to place an implant into the eye during a one-time outpatient procedure. After the procedure, the Retina Specialist may schedule follow-up visits to make sure the eye has healed.
The most serious side effects of SUSVIMO are:
The majority of side effects were related to surgery. If you choose SUSVIMO treatment and any side effects occur, notify your doctor immediately. The most common side effects of SUSVIMO were:
If necessary, SUSVIMO can be removed in an outpatient procedure.
Get help understanding your insurance coverage and assistance options from Genentech Ophthalmology Access Solutions. Genentech Ophthalmology Access Solutions can help you learn if your health insurance covers SUSVIMO treatment and refer you to appropriate financial assistance options if you are eligible.
Have questions or need assistance? Just call (833) EYE-GENE/(833) 393-4363 and one of our representatives will be with you soon. Our representatives are available Monday–Friday, 9 am to 8 pm Eastern Time.
Take advantage of these downloadable resources to help you stay on track with your treatment.
This brochure contains important information about wet AMD and how SUSVIMO can help you get the most out of your treatment.
This brochure contains important information about wet AMD and how SUSVIMO can help you get the most out of your treatment.
This brochure provides important information about the SUSVIMO procedures and how you can prepare for them.
This brochure provides important information about the SUSVIMO procedures and how you can prepare for them.
An Amsler grid is a simple test that can help you monitor your vision at home. It is used to check whether you see blurry, distorted, or wavy lines, missing corners, and dark or blank spots.
An Amsler grid is a simple test that can help you monitor your vision at home. It is used to check whether you see blurry, distorted, or wavy lines, missing corners, and dark or blank spots.
Every person should get the SUSVIMO treatment their doctor prescribed, and Genentech offers programs to help make this happen.
Every person should get the SUSVIMO treatment their doctor prescribed, and Genentech offers programs to help make this happen.
These organizations offer information and support for people living with wet AMD.
BrightFocus Foundation is a leading private funder of scientific research and public awareness to end macular degeneration, glaucoma, and Alzheimer’s disease.
Established in 1971, the Foundation Fighting Blindness is the world’s leading organization committed to finding treatments and cures for blinding retinal diseases.
Macular Degeneration Support is a strong voice and a principal resource for senior adults who are living with low vision. The organization has been serving thousands of people worldwide since 1994.
Prevent Blindness is the nation’s leading volunteer eye health and safety organization, dedicated to preventing blindness and preserving sight. Prevent Blindness promotes access to eye care, education, empowerment, and support for those with vision loss due to eye disease.
AMD=age-related macular degeneration.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.